Insmed (INSM) PT Lowered to $43 at Stifel, Following Earnings

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY

6. HCP
7. BA
8. SNAP
9. TMUS
10. BIIB

Price: $24.92 -3.45%

Rating Summary:
25 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13

Stifel analyst Stephen D. Willey lowered the price target on Insmed (NASDAQ: INSM) to $43.00 (from $50.00) while maintaining a Buy rating.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!